Vitamin D production in psoriasis patients increases less with narrowband than with broadband ultraviolet B phototherapy

• Published in: Photodermatology, photoimmunology & photomedicine photoimmunology & photomedicine, 2009-06, Vol.25 (3), p.119-123
• Main Authors: Osmancevic, Amra, Landin-Wilhelmsen, Kerstin, Larkö, Olle, Wennberg, Ann-Marie, Krogstad, Anne Lene
• Format: Article
• Language: English
• Subjects: Adult; Aged; Biological and medical sciences; biosynthesis; blood; Dermatology; Female; Humans; Male; MEDICAL AND HEALTH SCIENCES; Medical sciences; MEDICIN OCH HÄLSOVETENSKAP; Middle Aged; Phototherapy; Psoriasis; Psoriasis - blood; Psoriasis - therapy; Psoriasis. Parapsoriasis. Lichen; therapy; Ultraviolet Rays; UVB therapy; Vitamin D; Vitamin D - biosynthesis; Vitamin D - blood
• ISSN: 0905-4383; 1600-0781; 1600-0781
• DOI: 10.1111/j.1600-0781.2009.00418.x

Background: Phototherapy of psoriasis is an effective treatment. In addition to standard broadband ultraviolet radiation B (UVB), (280–320 nm), narrowband phototherapy (NBUVB) (monochromatic UV between 311 and 312 nm) has become an important treatment for psoriasis. The same wavelength range of UVB (290–315 nm) induces synthesis of vitamin D. The aim was to compare the effect of broadband with NBUVB therapy on vitamin D synthesis in patients with psoriasis. Methods: Sixty‐eight Caucasian patients (17 women and 51 men) mean age 54.1 ± 16.0 years, with active plaque psoriasis, were treated with broadband UVB (n=26) or NBUVB (n=42) two to three times/week for 8–12 weeks. The serum concentrations of 25‐hydroxyvitamin D (25(OH)D3), 1,25‐dihydroxyvitamin D (1,25(OH)2D3), intact parathyroid hormone (PTH), calcium and creatinine were measured before the first exposure and after the last dose of radiation. Results: In broadband UVB treated patients, 25(OH)D3 increased from 37.9 ± 16.9 to 69.4 ± 19.7 ng/ml (P